Skip to main content
SpringerLink
Log in

Medication-related pharmacological manipulations of nicotine self-administration in the rat maintained on fixed- and progressive-ratio schedules of reinforcement

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

The use of animal models to study existing medications for smoking cessation can elucidate the mechanism(s) of action of cessation agents and further validate the models for medication development.

Objective

The objective of the study was to evaluate the response of nicotine self-administration (NSA) to pharmacological agents related to the smoking cessation medication bupropion and to nicotine dosing mimicking nicotine replacement on fixed-ratio (FR) and progressive-ratio (PR) schedules of reinforcement.

Materials and methods

NSA was maintained at a nicotine dose of 30 μg/kg/infusion i.v. in rats trained on FR5 and PR40% schedules. Pharmacological manipulations related to bupropion were examined by treating animals with a dopamine reuptake inhibitor [GBR 12909 (GBR)], a norepinephrine reuptake inhibitor [nisoxetine (NIS)], and a nicotinic antagonist [dihydro-β-erythroidine (DHβE)]. The effect of nicotine replacement was examined on the PR schedule by chronic dosing with osmotic minipumps.

Results

Significant treatment effects occurred with NIS and combinations of NIS–DHβE and with GBR on response rates. Chronic nicotine dosing reduced self-administration. The two schedules yielded different results with some treatments.

Conclusions

Noradrenergic–nicotinic cholinergic interactions and enhanced responding consequent to dopamine reuptake inhibition may be part of the complex behavioral pharmacology of bupropion-like compounds. Observation of differential results with the two schedules has implication for the use of self-administration techniques to elaborate the mechanisms of dependence as well as drug discovery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Arnold JM, Roberts DC (1997) A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacol Biochem Behav 57:441–447

    Article  PubMed  CAS  Google Scholar 

  • Barrett AC, Miller JR, Dohrmann JM, Caine SB (2004) Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats. Neuropharmacology 47(Suppl 1):256–273

    Article  PubMed  CAS  Google Scholar 

  • Benwell ME, Balfour DJ (1997) Regional variation in the effects of nicotine on catecholamine overflow in rat brain. Eur J Pharmacol 325:13–20

    Article  PubMed  CAS  Google Scholar 

  • Bruijnzeel AW, Markou A (2003) Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats. Synapse 50:20–28

    Article  PubMed  CAS  Google Scholar 

  • Caggiula AR, Donny EC, White AR, Chaudhri N, Booth S, Gharib MA, Hoffman A, Perkins KA, Sved AF (2001) Cue dependency of nicotine self-administration and smoking. Pharmacol Biochem Behav 70:515–530

    Article  PubMed  CAS  Google Scholar 

  • Chaudhri N, Caggiula AR, Donny EC, Booth S, Gharib M, Craven L, Palmatier MI, Liu X, Sved AF (2007) Self-administered and noncontingent nicotine enhance reinforced operant responding in rats: impact of nicotine dose and reinforcement schedule. Psychopharmacology (Berl) 190:353–362

    Article  CAS  Google Scholar 

  • Corrigall WA, Coen KM (1989) Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology (Berl) 99:473–478

    Article  CAS  Google Scholar 

  • Corrigall WA, Coen KM, Adamson KL (1994) Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653:278–284

    Article  PubMed  CAS  Google Scholar 

  • Corrigall WA, Coen KM, Zhang J, Adamson KL (2001) GABA mechanisms in the pedunculopontine tegmental nucleus influence particular aspects of nicotine self-administration selectively in the rat. Psychopharmacology (Berl) 158:190–197

    Article  CAS  Google Scholar 

  • Cousins MS, Stamat HM, de Wit H (2001) Acute doses of d-amphetamine and bupropion increase cigarette smoking. Psychopharmacology (Berl) 157:243–253

    Article  CAS  Google Scholar 

  • Donny EC, Caggiula AR, Knopf S, Brown C (1995) Nicotine self-administration in rats. Psychopharmacology 122:190–194

    Article  Google Scholar 

  • Donny EC, Caggiula AR, Mielke MM, Booth S, Gharib MA, Hoffman A, Maldovan V, Shupenko C, McCallum SE (1999) Nicotine self-administration in rats on a progressive ratio schedule of reinforcement. Psychopharmacology (Berl) 147:135–142

    Article  CAS  Google Scholar 

  • Dwoskin LP, Rauhut AS, King-Pospisil KA, Bardo MT (2006) Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Rev 12:178–207

    Article  PubMed  Google Scholar 

  • Felix R, Levin ED (1997) Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats. Neuroscience 81:1009–1017

    Article  PubMed  CAS  Google Scholar 

  • Fu Y, Matta SG, James TJ, Sharp BM (1998) Nicotine-induced norepinephrine release in the rat amygdala and hippocampus is mediated through brainstem nicotinic cholinergic receptors. J Pharmacol Exp Ther 284:1188–1196

    PubMed  CAS  Google Scholar 

  • Fu Y, Matta SG, Brower VG, Sharp BM (2001) Norepinephrine secretion in the hypothalamic paraventricular nucleus of rats during unlimited access to self-administered nicotine: an in vivo microdialysis study. J Neurosci 21:8979–8989

    PubMed  CAS  Google Scholar 

  • Fu Y, Matta SG, Kane VB, Sharp BM (2003) Norepinephrine release in amygdala of rats during chronic nicotine self-administration: an in vivo microdialysis study. Neuropharmacology 45:514–523

    Article  PubMed  CAS  Google Scholar 

  • Glick SD, Maisonneuve IM, Kitchen BA (2002) Modulation of nicotine self-administration in rats by combination therapy with agents blocking alpha 3 beta 4 nicotinic receptors. Eur J Pharmacol 448:185–191

    Article  PubMed  CAS  Google Scholar 

  • Grottick AJ, Trube G, Corrigall WA, Huwyler J, Malherbe P, Wyler R, Higgins GA (2000) Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine. J Pharmacol Exp Ther 294:1112–1119

    PubMed  CAS  Google Scholar 

  • Guillem K, Vouillac C, Azar MR, Parsons LH, Koob GF, Cador M, Stinus L (2006) Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats. Eur J Neurosci 24:3532–3540

    Article  PubMed  Google Scholar 

  • Harris AC, Pentel PR, Lesage MG (2007) Prevalence, magnitude, and correlates of an extinction burst in drug-seeking behavior in rats trained to self-administer nicotine during unlimited access (23 h/day) sessions. Psychopharmacology 194:395–402

    Article  PubMed  CAS  Google Scholar 

  • Harrison AA, Gasparini F, Markou A (2002) Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats. Psychopharmacology (Berl) 160:56–66

    Article  CAS  Google Scholar 

  • Hennings EC, Kiss JP, De Oliveira K, Toth PT, Vizi ES (1999) Nicotinic acetylcholine receptor antagonistic activity of monoamine uptake blockers in rat hippocampal slices. J Neurochem 73:1043–1050

    Article  PubMed  CAS  Google Scholar 

  • Howell LL, Byrd LD (1991) Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey. J Pharmacol Exp Ther 258:178–185

    PubMed  CAS  Google Scholar 

  • Howell LL, Wilcox KM (2001) The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates. J Pharmacol Exp Ther 298:1–6

    PubMed  CAS  Google Scholar 

  • Kenny PJ, Markou A (2006) Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology 31:1203–1211

    PubMed  CAS  Google Scholar 

  • Kimmel HL, Holtzman SG (1998) Opioid receptor agonists and antagonists alter GBR12909-induced turning in the rat. Eur J Pharmacol 343:119–127

    Article  PubMed  CAS  Google Scholar 

  • Lanca AJ, Adamson KL, Coen KM, Chow BL, Corrigall WA (2000) The pedunculopontine tegmental nucleus and the role of cholinergic neurons in nicotine self-administration in the rat: a correlative neuroanatomical and behavioral study. Neuroscience 96:735–742

    Article  PubMed  CAS  Google Scholar 

  • Lerman C, Lesage MG, Perkins KA, O’Malley SS, Siegel SJ, Benowitz NL, Corrigall WA (2007) Translational research in medication development for nicotine dependence. Nat Rev Drug Discov 6:746–762

    Article  PubMed  CAS  Google Scholar 

  • LeSage MG, Keyler DE, Shoeman D, Raphael D, Collins G, Pentel PR (2002) Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h/day access to nicotine. Pharmacol Biochem Behav 72:279–289

    Article  PubMed  CAS  Google Scholar 

  • LeSage MG, Keyler DE, Collins G, Pentel PR (2003) Effects of continuous nicotine infusion on nicotine self-administration in rats: relationship between continuously infused and self-administered nicotine doses and serum concentrations. Psychopharmacology (Berl) 170:278–286

    Article  CAS  Google Scholar 

  • Lindsey KP, Wilcox KM, Votaw JR, Goodman MM, Plisson C, Carroll FI, Rice KC, Howell LL (2004) Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging. J Pharmacol Exp Ther 309:959–969

    Article  PubMed  CAS  Google Scholar 

  • Malin DH, Lake JR, Upchurch TP, Shenoi M, Rajan N, Schweinle WE (1998) Nicotine abstinence syndrome precipitated by the competitive nicotinic antagonist dihydro-beta-erythroidine. Pharmacol Biochem Behav 60:609–613

    Article  PubMed  CAS  Google Scholar 

  • Mansbach RS, Chambers LK, Rovetti CC (2000) Effects of the competitive nicotinic antagonist erysodine on behavior occasioned or maintained by nicotine: comparison with mecamylamine. Psychopharmacology (Berl) 148:234–242

    Article  CAS  Google Scholar 

  • Markou A, Weiss F, Gold LH, Caine SB, Schulteis G, Koob GF (1993) Animal models of drug craving. Psychopharmacology (Berl) 112:163–182

    Article  CAS  Google Scholar 

  • McGregor A, Roberts DC (1993) Dopaminergic antagonism within the nucleus accumbens or the amygdala produces differential effects on intravenous cocaine self-administration under fixed and progressive ratio schedules of reinforcement. Brain Res 624:245–252

    Article  PubMed  CAS  Google Scholar 

  • McGregor A, Roberts DC (1995) Effect of medial prefrontal cortex injections of SCH 23390 on intravenous cocaine self-administration under both a fixed and progressive ratio schedule of reinforcement. Behav Brain Res 67:75–80

    Article  PubMed  CAS  Google Scholar 

  • Miller DK, Wong EH, Chesnut MD, Dwoskin LP (2002) Reboxetine: functional inhibition of monoamine transporters and nicotinic acetylcholine receptors. J Pharmacol Exp Ther 302:687–695

    Article  PubMed  CAS  Google Scholar 

  • Paterson NE, Markou A (2004) Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats. Psychopharmacology 173:64–72

    Article  PubMed  CAS  Google Scholar 

  • Paterson NE, Markou A (2005) The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats. Psychopharmacology 179:255–261

    Article  PubMed  CAS  Google Scholar 

  • Paterson NE, Froestl W, Markou A (2004) The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology (Berl) 172:179–186

    Article  CAS  Google Scholar 

  • Paterson NE, Semenova S, Markou A (2008) The effects of chronic versus acute desipramine on nicotine withdrawal and nicotine self-administration in the rat. Psychopharmacology 198:351–362

    Article  PubMed  CAS  Google Scholar 

  • Perkins KA, Grobe JE, Stiller RL, Fonte C, Goettler JE (1992) Nasal spray nicotine replacement suppresses cigarette smoking desire and behavior. Clin Pharmacol Ther 52:627–634

    PubMed  CAS  Google Scholar 

  • Perkins KA, Lerman C, Keenan J, Fonte C, Coddington S (2004) Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers. Nicotine Tob Res 6:501–507

    Article  PubMed  CAS  Google Scholar 

  • Rahman S, Zhang J, Corrigall WA (2004) Local perfusion of nicotine differentially modulates somatodendritic dopamine release in the rat ventral tegmental area after nicotine preexposure. Neurochem Res 29:1687–1693

    Article  PubMed  CAS  Google Scholar 

  • Rauhut AS, Mullins SN, Dwoskin LP, Bardo MT (2002) Reboxetine: attenuation of intravenous nicotine self-administration in rats. J Pharmacol Exp Ther 303:664–672

    Article  PubMed  CAS  Google Scholar 

  • Rauhut AS, Neugebauer N, Dwoskin LP, Bardo MT (2003) Effect of bupropion on nicotine self-administration in rats. Psychopharmacology (Berl) 169:1–9

    Article  CAS  Google Scholar 

  • Roberts DC, Bennett SA, Vickers GJ (1989) The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology (Berl) 98:408–411

    Article  CAS  Google Scholar 

  • Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley FD 3rd, Williams KE (2007) Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52:985–994

    Article  PubMed  CAS  Google Scholar 

  • Rothman RB, Glowa JR (1995) A review of the effects of dopaminergic agents on humans, animals, and drug seeking behavior, and its implications for medication development. Focus on GBR 12909. Mol Neurobiol 11:1–19

    Article  PubMed  CAS  Google Scholar 

  • Schenk S (2002) Effects of GBR 12909, WIN 35,428 and indatraline on cocaine self-administration and cocaine seeking in rats. Psychopharmacology (Berl) 160:263–270

    Article  CAS  Google Scholar 

  • Sharp BM, Matta SG (1993) Detection by in vivo microdialysis of nicotine-induced norepinephrine secretion from the hypothalamic paraventricular nucleus of freely moving rats: dose-dependency and desensitization. Endocrinology 133:11–19

    Article  PubMed  CAS  Google Scholar 

  • Shoaib M, Sidhpura N, Shafait S (2003) Investigating the actions of bupropion on dependence-related effects of nicotine in rats. Psychopharmacology (Berl) 165:405–412

    CAS  Google Scholar 

  • Skjoldager P, Winger G, Woods JH (1993) Effects of GBR 12909 and cocaine on cocaine-maintained behavior in rhesus monkeys. Drug Alcohol Depend 33:31–39

    Article  PubMed  CAS  Google Scholar 

  • Stafford D, LeSage MG, Rice KC, Glowa JR (2001) A comparison of cocaine, GBR 12909, and phentermine self-administration by rhesus monkeys on a progressive-ratio schedule. Drug Alcohol Depend 62:41–47

    Article  PubMed  CAS  Google Scholar 

  • Stoker AK, Semenova S, Markou A (2008) Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice. Neuropsychopharmacol 54:1223–1232

    CAS  Google Scholar 

  • Stolerman IP, Chandler CJ, Garcha HS, Newton JM (1997) Selective antagonism of behavioural effects of nicotine by dihydro-beta-erythroidine in rats. Psychopharmacology (Berl) 129:390–397

    Article  CAS  Google Scholar 

  • Summers KL, Giacobini E (1995) Effects of local and repeated systemic administration of (−)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex. Neurochem Res 20:753–759

    Article  PubMed  CAS  Google Scholar 

  • Szasz BK, Vizi ES, Kiss JP (2007) Nicotinic acetylcholine receptor antagonistic property of the selective dopamine uptake inhibitor, GBR-12909 in rat hippocampal slices. Neuroscience 145:344–349

    Article  PubMed  CAS  Google Scholar 

  • Tella SR (1995) Effects of monoamine reuptake inhibitors on cocaine self-administration in rats. Pharmacol Biochem Behav 51:687–692

    Article  PubMed  CAS  Google Scholar 

  • Tyler TD, Tessel RE (1979) Amphetamine’s locomotor stimulant and norepinephrine-releasing effects: evidence for selective antagonist by nisoxetine. Psychopharmacology 64:291–296

    Article  PubMed  CAS  Google Scholar 

  • Walters CL, Brown S, Changeux JP, Martin B, Damaj MI (2006) The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology (Berl) 184:339–344

    Article  CAS  Google Scholar 

  • Watkins SS, Epping-Jordan MP, Koob GF, Markou A (1999) Blockade of nicotine self-administration with nicotinic antagonists in rats. Pharmacol Biochem Behav 62:743–751

    Article  PubMed  CAS  Google Scholar 

  • Watkins SS, Stinus L, Koob GF, Markou A (2000) Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. J Pharmacol Exp Ther 292:1053–1064

    PubMed  CAS  Google Scholar 

  • Weeks JR (1981) An improved pneumatic syringe for self-administration of drugs by rats. Pharmacol Biochem Behav 14:573–574

    Article  PubMed  CAS  Google Scholar 

  • Weinshenker D, Schroeder JP (2007) There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology 32:1433–1451

    Article  PubMed  CAS  Google Scholar 

  • Williams M, Robinson JL (1984) Binding of the nicotinic cholinergic antagonist, dihydro-beta-erythroidine, to rat brain tissue. J Neurosci 4:2906–2911

    PubMed  CAS  Google Scholar 

  • Zhou J (2004) Norepinephrine transporter inhibitors and their therapeutic potential. Drugs Future 29:1235–1244

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Mark LeSage, Ph.D., for his insightful comments on the manuscript and acknowledge the outstanding statistical support provided by Tamara Arenovich, M.Sc., and Gautam Sajeer, M.Sc., of the Biostatistical Consulting Services at CAMH.

Author information

Authors and Affiliations

  1. Smoking and Nicotine Dependence Research Unit, Department of Neuroscience, Centre for Addiction & Mental Health, Toronto, ON, M5S 2S1, Canada

    Kathleen M. Coen & K. Laurel Adamson

  2. Department of Psychiatry, University of Minnesota, Minneapolis, MN, USA

    William A. Corrigall

  3. Minneapolis Medical Research Foundation, Hennepin County Medical Center, 914 S 8th Street, Minneapolis, MN, 55414, USA

    William A. Corrigall

Authors
  1. Kathleen M. Coen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Laurel Adamson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. William A. Corrigall
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William A. Corrigall.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coen, K.M., Adamson, K.L. & Corrigall, W.A. Medication-related pharmacological manipulations of nicotine self-administration in the rat maintained on fixed- and progressive-ratio schedules of reinforcement. Psychopharmacology 201, 557–568 (2009). https://doi.org/10.1007/s00213-008-1321-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-008-1321-6

Keywords

Search

Navigation